Kathryn Greiner

Ms Greiner is well known in the Australian business and not-for-profit community most recently as Chairman of the Financial Planning Association of Australia.

Kathryn is, or has been, the Chairman of the Salvation Army (Sydney), a member of the international council of the Asia Society, a member of the advisory board for LEK Consulting and Chairman of the Sydney Peace Prize Foundation amongst other roles.

She has a Bachelor of Social Work from the University of New South Wales with post-graduate studies at both Macquarie University and Boise State College in the United States.

Alastair Davidson

Alastair Davidson is Managing Director of Aurora Funds Management based in Sydney. Prior to this he has held executive positions in the banking and financial services industry for 15 years in the UK, USA and Australia. This included Salomon Smith Barney in Sydney for 8 years as co-head of its new product group, specialising in equity derivatives. He is a member of the Institute of Chartered Accountants in Scotland and has an Honours degree in Economics from the University of St Andrews.

Harry Karelis

Harry Karelis is the Managing Director of Biotech Capital Ltd. Harry graduated from The University of Western Australia with Bachelors and Honours in Science majoring in Biochemistry and Microbiology as well as a Masters in Business Administration.

He is an Associate of the Securities Institute of Australia, a Fellow of the Australian Institute of Company Directors and has qualified as a Chartered Financial Analyst (CFA) from the Association of Investment Management and Research (AIMR) in the United States.

He has a background in financial analysis and funds management both in Australia and overseas including several years working in Singapore where he was employed by a major international bank.

Professor Tony Basten

Professor Basten is the Executive Director of the Centenary Institute of Cancer Medicine & Cell Biology, Professor of Immunology at the University of Sydney, Director of the Central Sydney Area Health Clinical Immunology and Allergy Service and Chief Scientist of the Institute's biotech company, CenTec. He was winner of the inaugural Wellcome Australia Medal for Distinguished Discovery and its Demonstrated Use, a Florey Lecturer of the Royal Society, London and the Chief Commonwealth Advisor on the medical and scientific aspects of HIV/AIDS.

He is a clinician/scientist and his research spans the interface between the laboratory and the bedside. On the commercial front he has secured, together with colleagues, a number of industry grants and experience in the running of clinical trials and has served on the scientific advisory boards of biotech companies. In recognition of his contributions to medicine and health and medical research he became an Officer in the General Division Order of Australia and was elected to Fellowship of the Australian Academies of Science and Technological Sciences and Engineering.

Investment Team

BioTech Capital has contracted Titan Bioventures Management to act as investment manager.
Click here to view details on the investment team.